Literature DB >> 6868058

Complete heart block--another HLA B27 associated disease manifestation.

L Bergfeldt, E Möller.   

Abstract

An increased prevalence of ankylosing spondylitis and other HLA B27-associated rheumatic diseases has recently been demonstrated in a group of men with permanent pacemaker-treatment. The purpose of the present study was to find out if HLA B27 was associated with severe bradyarrhythmias also in the absence of rheumatic disease. The frequency of B27 was determined in 83 permanently paced men with complete heart block, in whom presence of radiological or clinical signs of a B27-associated rheumatic disease had been excluded. Eighty-four healthy subjects were HLA typed for comparison. HLA B27 was found in 17% of the patients and in 6% of the controls, a significant difference with P = 0.017 (Fisher's exact test). The present study suggests that, in a subgroup of patients with complete heart block, the development of heart block is B27-associated, and that the pathophysiological mechanism is similar to that leading to ankylosing spondylitis. Another B27-associated disease manifestation has been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6868058     DOI: 10.1111/j.1399-0039.1983.tb00188.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

Review 1.  The heart in ankylosing spondylitis.

Authors:  T W O'Neill; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Permanent pacemakers in nonagenarians.

Authors:  J E Elizabeth; G J Green
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

3.  The authors reply.

Authors:  D B Shaw; C A Kekwick; D Veale; J Gowers; T Whistance
Journal:  Br Heart J       Date:  1986-07

4.  Heart conduction disturbance: an HLA-B27 associated disease.

Authors:  A J Peeters; S ten Wolde; M I Sedney; R R de Vries; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

5.  Seronegative spondylarthropathy without spine involvement in Behçet's syndrome.

Authors:  I Olivieri; F Cantini; V Napoli; G Braccini; A Padula; G Pasero
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

6.  Platelet aggregating activity in serum from patients with HLA-B27 associated rheumatic and cardiac disorders: a possible link to the proliferative vascular changes.

Authors:  L Bergfeldt; O Edhag; G Holm; R Norberg
Journal:  Br Heart J       Date:  1991-04

Review 7.  Axial spondyloarthritis: the heart of the matter.

Authors:  Lianne S Gensler
Journal:  Clin Rheumatol       Date:  2015-05-10       Impact factor: 2.980

8.  Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristics.

Authors:  L Bergfeldt; H Vallin; O Edhag
Journal:  Br Heart J       Date:  1984-02

9.  Atrioventricular conduction disturbance as an early feature of Reiter's syndrome.

Authors:  J F Haverman; G A Van Albada-Kuipers; H J Dohmen; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

10.  Lifetime Risks of Valvular Heart Disease and Pacemaker Use in Patients With Ankylosing Spondylitis.

Authors:  Michael M Ward
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.